Venture Capital · Paris (France), Munich (Germany) · Founded 2009
Kurma Partners is a major player in funding healthcare and biotechnology in Europe. They work closely with research teams to create and support high-tech companies, providing capital and expertise. Kurma Partners has a strong network of partners and is committed to sustainable development and ESG practices.
Pre-Seed, Seed, Series A, Series B
AgTech, BioTech, Diagnostics, MedTech
ABM, Pharmareva, Altamira Therapeutics, Amolyt Pharma, AM Pharma, Argobio Studio, Arkhn, Asarina Pharma, Asceneuron, Avidicure, Axithra, BioSerinity, BliNK, Cardiologs, Charles, Coave Therapeutics, Corlieve Therapeutics, Corteria, DAMAE Medical, Deepull, DNA Script, Emergence, Flamingo Therapeutics, Ganymed Robotics, Germitec, Hopia, ImCheck, IO Biotech, Kiro, Kurma Acc茅l茅ration, MedLumics, Meiogenix, M茅mo Tx, Minroyx, NaoX Technologies, Omnidoc, Orphazyme, OxThera, Pantera, PathoQuest, Pharvaris, Poppins, Raidium, RyCarma, Safe Orthopaedics, SciRhom, Sensome, Shorla Oncology, Smartcatch, Spotlight Medical, StatDx, STEP Pharma, Stilla Technologies, Sunrise, Synendos Therapeutics, Tacalyx, Talix, Vico Therapeutics, Vivet Therapeutics, Xeltis, Zealand Pharma